Data / Research funding / Fibroid Tumors (Uterine)
Fibroid Tumors (Uterine): 51 NIH awards ($49.6M) to 29 organizations
51 NIH awards ($49.6M) in the NIH spending category Fibroid Tumors (Uterine), to 29 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
51 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| A Safe, Fast, and Cost-Effective System for Tissue Removal in Laparoscopic Hysterectomy and Other Minimally Invasive Surgery | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $3,850,176 | September 1, 2022 | August 31, 2027 | FRANCIS, DANIEL | reporter.nih.gov |
| Pathological reprogramming of the m6A epitranscriptome in uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,245,895 | August 9, 2021 | May 31, 2027 | BOYER, THOMAS G | reporter.nih.gov |
| Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sample | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $2,906,922 | November 11, 2020 | July 31, 2023 | AL-HENDY, AYMAN | reporter.nih.gov |
| Role of senescent cells in uterine fibroid pathogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,413,780 | March 15, 2023 | December 31, 2027 | SEGARS, JAMES H. | reporter.nih.gov |
| Reactive Oxygen Species in the Initiation, Survival and Racial Disparity of Uterine Leiomyoma | NIH | National Cancer Institute | 2021 to 2025 | $2,288,657 | August 6, 2020 | May 31, 2027 | KIM, JI-YONG JULIE | reporter.nih.gov |
| Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,042,515 | September 1, 2023 | June 30, 2027 | JACOBY, VANESSA | reporter.nih.gov |
| Environmental Pollutants and AHR pathway in Uterine Leiomyoma | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,843,009 | December 13, 2022 | October 31, 2027 | BULUN, SERDAR E. | reporter.nih.gov |
| Long Term Effectiveness of Uterine Sparing Fibroid Treatments | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,827,279 | September 1, 2023 | August 31, 2027 | WEGIENKA, GANESA REBECCA | reporter.nih.gov |
| Molecular basis of MED12 in the pathogenesis of uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,806,512 | August 1, 2017 | April 30, 2027 | BOYER, THOMAS G | reporter.nih.gov |
| Mechanisms of actions(s) of simvastatin in uterine leiomyoma | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,719,127 | August 1, 2018 | July 31, 2025 | BORAHAY, MOSTAFA A. | reporter.nih.gov |
| Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,676,107 | February 15, 2018 | July 31, 2023 | BOYER, THOMAS G | reporter.nih.gov |
| Tryptophan metabolism and its role in fibroid pathogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,537,148 | September 30, 2022 | June 30, 2027 | KHORRAM, OMID A. | reporter.nih.gov |
| Examination of factors influencing the racial disparity in fibroid incidence | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,523,924 | August 1, 2024 | April 30, 2029 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Steroid Receptor Crosstalk and Pathogenesis of Uterine Fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,460,240 | August 2, 2020 | April 30, 2026 | WHIRLEDGE, SHANNON D | reporter.nih.gov |
| Evaluating the impact of altered gene expression on uterine fibroid risk in African ancestry populations | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,402,915 | August 22, 2024 | May 31, 2029 | VELEZ EDWARDS, DIGNA R | reporter.nih.gov |
| Patient-specific targeting of uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,359,046 | August 29, 2019 | April 30, 2025 | TEIXEIRA, JOSE M. | reporter.nih.gov |
| Mechanism of Long Non-coding RNAs Action in leiomyoma | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,296,607 | September 8, 2020 | June 30, 2025 | KHORRAM, OMID A. | reporter.nih.gov |
| Botanical derived progestins and their impact on women's health | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $1,151,280 | May 1, 2016 | February 29, 2028 | BURDETTE, JOANNA E | reporter.nih.gov |
| REST-MED12 Pathways in the Regulation of Estrogen - Progesterone Sensitivity in Uterine Leiomyoma | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,076,960 | August 16, 2024 | May 31, 2029 | CHENNATHUKUZHI, VARGHEESE MANI | reporter.nih.gov |
| Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,034,609 | September 26, 2019 | August 31, 2025 | TAYLOR, HUGH SMITH | reporter.nih.gov |
| A New Robot to Replace Hysterectomies with Minimally Invasive Uterine-Sparing Interventions | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 to 2025 | $1,014,640 | May 8, 2024 | February 29, 2028 | WEBSTER, ROBERT JAMES | reporter.nih.gov |
| 3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $934,920 | September 26, 2019 | August 31, 2025 | GONZALEZ, FRANK | reporter.nih.gov |
| ELLAS Environment, Leiomyomas, Latinas and Adiposity Study | NIH | National Institute on Minority Health and Health Disparities | 2021 | $700,230 | September 28, 2016 | January 31, 2023 | MARSH, ERICA E | reporter.nih.gov |
| Modeling and Characterizing the Genomic Consequences of MED12 Mutations in Uterine Fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $688,000 | August 1, 2025 | May 31, 2030 | ADLI, MAZHAR | reporter.nih.gov |
| The STAT3 Pathway in Uterine Leiomyoma: A Therapeutic Target | NIH | National Cancer Institute | 2025 | $681,337 | January 1, 2025 | December 31, 2029 | BULUN, SERDAR E. | reporter.nih.gov |
| Large-scale studies in eMERGE to discover the genetic determinants of uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $649,084 | September 23, 2017 | June 30, 2024 | VELEZ EDWARDS, DIGNA R | reporter.nih.gov |
| Environmental risk factors for uterine fibroids: a prospective ultrasound study | NIH | National Institute of Environmental Health Sciences | 2024 | $622,163 | September 1, 2017 | August 31, 2025 | WEGIENKA, GANESA REBECCA | reporter.nih.gov |
| Environmental risk factors for uterine fibroids: a prospective ultrasound study | NIH | National Institute of Environmental Health Sciences | 2021 | $594,096 | September 1, 2017 | August 31, 2023 | WEGIENKA, GANESA REBECCA | reporter.nih.gov |
| 1/4 Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $588,419 | September 26, 2019 | August 31, 2025 | SEGARS, JAMES H. | reporter.nih.gov |
| Child Abuse and Risk of Gynecologic Disease in a North American Cohort | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $478,630 | August 23, 2024 | July 31, 2027 | WISE, LAUREN A | reporter.nih.gov |
| Predicting Outcomes for Uterine Fibroid Embolization by using Deep Learning of Paired MRI Scans | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $466,125 | August 21, 2023 | July 31, 2025 | MOSADEGH, BOBAK | reporter.nih.gov |
| Prevalence, Risk Factors, and Clinical Presentation of Uterine Leiomyomas by HIV Status | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $438,926 | August 19, 2025 | July 31, 2027 | STOCKMAN, JAMILA KINSHASA | reporter.nih.gov |
| Developing a baboon model for uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $431,750 | August 1, 2024 | July 31, 2027 | TEIXEIRA, JOSE M. | reporter.nih.gov |
| Evaluation of Uterine Fibroids by Contrast Enhanced Ultrasound (CEUS) and Subharmonic-Aided Pressure Estimation (SHAPE) Pre and Post Uterine Artery Embolization (UAE) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $429,000 | August 1, 2024 | July 31, 2027 | MACHADO, PRISCILLA | reporter.nih.gov |
| Ultrasound-guided Intrinsic Threshold Histotripsy for the Non-invasive Ablation of Uterine Fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $422,176 | August 15, 2022 | July 31, 2025 | VLAISAVLJEVICH, ELI | reporter.nih.gov |
| Early Life Adversities and the Risk of Uterine Fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $416,054 | August 1, 2024 | July 31, 2026 | VINES, ANISSA I | reporter.nih.gov |
| Med12 mechanisms of uterine leiomyoma formation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $321,367 | July 1, 2017 | June 30, 2022 | RAJKOVIC, ALEKSANDAR | reporter.nih.gov |
| Stress strain imaging for detection and characterization of endometriosis, adenomyosis and uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $299,942 | May 1, 2023 | April 30, 2025 | EGOROV, VLADIMIR | reporter.nih.gov |
| Influence of Diet, Iron Stores, and Toxic Metals on Uptakes and Effects on Uterine Fibroid Risk in African American Women | NIH | National Institute of Nursing Research | 2021 | $245,080 | April 10, 2019 | September 30, 2023 | UPSON, KRISTEN | reporter.nih.gov |
| Understanding the functional role of fibroid subtype mutations for drug discovery | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $235,934 | September 1, 2024 | August 31, 2026 | PAUL, EMMANUEL | reporter.nih.gov |
| Stem cell epigenetics in uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $205,542 | July 1, 2020 | June 30, 2024 | TEIXEIRA, JOSE M. | reporter.nih.gov |
| Myometrial stem cells | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $195,625 | June 1, 2020 | May 31, 2023 | TEIXEIRA, JOSE M. | reporter.nih.gov |
| In vivo Identification of stem cells in MED12 mutant leiomyoma | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $195,000 | May 1, 2020 | January 31, 2024 | KURITA, TAKESHI | reporter.nih.gov |
| Early reproductive aging: stress and uterine fibroid risk among black women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $187,901 | September 16, 2020 | August 31, 2023 | VINES, ANISSA I | reporter.nih.gov |
| Hypertension, antihypertensive treatment, and uterine fibroid diagnosis in an integrated healthcare system | NIH | National Heart, Lung, and Blood Institute | 2025 | $178,068 | March 4, 2025 | February 28, 2029 | MITRO, SUSANNA DECKER | reporter.nih.gov |
| Function of Long Non-Coding RNA MD1 in Leiomyoma Pathogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $154,100 | March 15, 2021 | February 29, 2024 | KHORRAM, OMID A. | reporter.nih.gov |
| Characterizing the Impact of Uterine Fibroids on the In-Utero Environment Offspring Consequences | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $100,170 | July 15, 2025 | June 30, 2027 | CAMERON, KATHERINE ELIZABETH | reporter.nih.gov |
| Biomechanics and mechanobiology of human uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $98,512 | September 1, 2024 | August 31, 2026 | FODERA, DANIELLA M | reporter.nih.gov |
| Semantic Evaluation of Environmental and Nutrition Factors Impacting Female Reproductive Disorders | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $66,398 | December 16, 2021 | June 16, 2023 | CHAN, LAUREN E | reporter.nih.gov |
| Effects of Surgical Removal of Uterine Fibroids on Atherosclerotic Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $49,538 | September 11, 2025 | September 10, 2026 | DITOSTO, JULIA | reporter.nih.gov |
| Racial Differences in Treatment with Hysterectomy: a Multilevel Investigation | NIH | National Institute on Minority Health and Health Disparities | 2021 | $1 | September 26, 2017 | September 6, 2021 | ROBINSON, WHITNEY RAGAN | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 26 | $12,594,306 | 0 | $0 |
| 2024 | 21 | $9,742,801 | 0 | $0 |
| 2023 | 20 | $8,226,035 | 0 | $0 |
| 2022 | 17 | $7,632,578 | 0 | $0 |
| 2021 | 23 | $11,355,716 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.